{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": [], "KeywordList": [], "GeneralNote": [], "PMID": "11575872", "DateCompleted": {"Year": "2001", "Month": "11", "Day": "01"}, "DateRevised": {"Year": "2007", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1354-523X", "JournalIssue": {"Volume": "7", "Issue": "4", "PubDate": {"Year": "2001", "Month": "Jul"}}, "Title": "Oral diseases", "ISOAbbreviation": "Oral Dis"}, "ArticleTitle": "LongoVital and herpes labialis: a randomised, double-blind, placebo-controlled study.", "Pagination": {"StartPage": "221", "EndPage": "225", "MedlinePgn": "221-5"}, "Abstract": {"AbstractText": ["LongoVital (LV) (DK. Reg. No. 5178/75) is a herbal-based tablet enriched with the recommended daily doses of vitamins. The present study was undertaken to investigate possible prevention of recurrent herpes labialis (RHL) during 4 months' daily intake of LV.", "Placebo-controlled, double-blind, randomised, clinical trial.", "Fifty-two patients with a minimum of 4 yearly HL episodes.", "The patients were given either LV or placebo for 4 months and followed-up for another 4 months. The number, duration and maximal size of lesions were assessed.", "Twenty-seven patients (Group A) received LV and 25 patients placebo (Group B). There were no statistically significant differences between Group A and Group B with respect to number, duration and size of lesions. Within Group A, however, there was a decrease in all three parameters after 2 months' intake of LV (P < 0.05). The decrease in the number of HL episodes in Group A lasted during the entire follow-up period (P < 0.05). At the end of the medication period, significantly more patients in Group A than in Group B assessed the number and duration of recurrences to be reduced compared with before the trial (P < 0.05).", "LV was not superior to placebo in the prevention of RHL although subjective assessment was in favour of LV, and the LV group had less episodes after 2 months on the tablets."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "The Oral Medicine Clinic, Peblinges\u00f8en, Copenhagen, Denmark. anne.l.pedersen@mail.tele.dk"}], "Identifier": [], "LastName": "Pedersen", "ForeName": "A", "Initials": "A"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Denmark", "MedlineTA": "Oral Dis", "NlmUniqueID": "9508565", "ISSNLinking": "1354-523X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Placebos"}, {"RegistryNumber": "0", "NameOfSubstance": "Tablets"}, {"RegistryNumber": "0", "NameOfSubstance": "Vitamins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Confidence Intervals"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": ["physiopathology", "prevention & control"], "DescriptorName": "Herpes Labialis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Patient Satisfaction"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Placebos"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": [], "DescriptorName": "Recurrence"}, {"QualifierName": [], "DescriptorName": "Statistics as Topic"}, {"QualifierName": [], "DescriptorName": "Statistics, Nonparametric"}, {"QualifierName": [], "DescriptorName": "Tablets"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Vitamins"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "9", "Day": "29", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "11", "Day": "3", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "9", "Day": "29", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11575872"]}}], "PubmedBookArticle": []}